Erratum to: Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up
Main Authors: | Marcus Wiemer, Sinisa Stojkovic, Alexander Samol, Zisis Dimitriadis, Juan M. Ruiz-Nodar, Ralf Birkemeyer, Jacques Monsegu, Gérard Finet, David Hildick-Smith, Damras Tresukosol, Enrique Garcia Novo, Jacques J. Koolen, Emanuele Barbato, Gian Battista Danzi, on behalf of NOBORI 2 investigators |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-05-01
|
Series: | Cardiovascular Diabetology |
Online Access: | http://link.springer.com/article/10.1186/s12933-017-0541-7 |
Similar Items
-
Thin Strut CoCr Biodegradable Polymer Biolimus A9-Eluting Stents versus Thicker Strut Stainless Steel Biodegradable Polymer Biolimus A9-Eluting Stents: Two-Year Clinical Outcomes
by: Ian B. A. Menown, et al.
Published: (2021-01-01) -
First clinical evidence characterizing safety and efficacy of the new CoCr Biolimus-A9 eluting stent: The Biomatrix Alpha™ registry
by: Ian B.A. Menown, et al.
Published: (2020-02-01) -
A Young Woman with Inevitable Limb Loss
by: Damras Tresukosol, et al.
Published: (2020-08-01) -
Amlodipine and Hydrochlorothiazide for Isolated Systolic Hypertension in the Thai Elderly
by: Damras Tresukosol, et al.
Published: (2005-09-01) -
The Ultimaster Biodegradable-Polymer Sirolimus-Eluting Stent: An Updated Review of Clinical Evidence
by: Alberto Chisari, et al.
Published: (2016-09-01)